Gemtuzumab

• CAT Number: I043942
• CAS Number: 220578-59-6
• Purity: ≥95%

Gemtuzumab（Cat No.:I043942）is a monoclonal antibody used in the treatment of acute myeloid leukemia (AML). It targets CD33, a cell surface protein expressed on leukemia cells, and delivers cytotoxic agents directly to these cells. By binding to CD33, Gemtuzumab induces cell death and helps reduce the number of leukemia cells in the body. It is typically used in combination with other chemotherapy agents. While it has shown efficacy in treating AML, its use has been associated with risks such as infusion reactions and potential liver toxicity, requiring careful monitoring during treatment.